DELAYED SKIN REACTIONS AFTER THE SECOND DOSE OF MRNA VACCINES AGAINST SARS-COV-2

被引：1
|
作者：
Martins-Filho, Paulo Ricardo [1 ]
Tenorio, Martha Debora Lira [2 ]
机构：
[1] Univ Fed Sergipe, Invest Pathol Lab, Aracaju, SE, Brazil
[2] Univ Fed Sergipe, Dermatol Residence Program, Aracaju, SE, Brazil
来源：
EXCLI JOURNAL | 2022年 / 21卷
关键词：
D O I：
10.17179/excli2022-5216
中图分类号：
Q [生物科学];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：1015 / 1018
页数：4
相关论文
共 50 条
  • [41] The development of DNA vaccines against SARS-CoV-2
    Khalid, Kanwal
    Poh, Chit Laa
    ADVANCES IN MEDICAL SCIENCES, 2023, 68 (02): : 213 - 226
  • [42] Nucleic Acid Vaccines against SARS-CoV-2
    Liu, Ying
    Ye, Qing
    VACCINES, 2022, 10 (11)
  • [43] mRNA Vaccines: Possible Tools to Combat SARS-CoV-2
    Yi, Changhua
    Yi, Yongxiang
    Li, Junwei
    VIROLOGICA SINICA, 2020, 35 (03) : 259 - 262
  • [44] Vaccinations against SARS-CoV-2 and the Skin
    Mockenhaupt, Maja
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 (03): : 223 - 224
  • [45] Positive aspects of the mRNA platform for SARS-CoV-2 vaccines
    Hajissa, Khalid
    Mussa, Ali
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (08) : 2445 - 2447
  • [46] SARS-CoV-2 mRNA Vaccines: Immunological Mechanism and Beyond
    Bettini, Emily
    Locci, Michela
    VACCINES, 2021, 9 (02) : 1 - 20
  • [47] mRNA Vaccines: Possible Tools to Combat SARS-CoV-2
    Changhua Yi
    Yongxiang Yi
    Junwei Li
    Virologica Sinica, 2020, 35 (03) : 259 - 262
  • [48] mRNA Vaccines: Possible Tools to Combat SARS-CoV-2
    Changhua Yi
    Yongxiang Yi
    Junwei Li
    Virologica Sinica, 2020, (03) : 259 - 262
  • [49] Seroconversion to mRNA SARS-CoV-2 Vaccines in Hematologic Patients
    Fattizzo, Bruno
    Bortolotti, Marta
    Rampi, Nicolo
    Cavallaro, Francesca
    Giannotta, Juri Alessandro
    Bucelli, Cristina
    Cassin, Ramona
    Da Via, Matteo Claudio
    Galassi, Giulia
    Noto, Alessandro
    Pettine, Loredana
    Rossi, Francesca Gaia
    Sciume, Mariarita
    Ceriotti, Ferruccio
    Consonni, Dario
    Barcellini, Wilma
    Baldini, Luca
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [50] Safety of the first dose of mRNA SARS-CoV-2 vaccines in patients with rheumatic and musculoskeletal diseases
    Connolly, Caoilfhionn M.
    Ruddy, Jake A.
    Boyarsky, Brian J.
    Avery, Robin K.
    Werbel, William A.
    Segev, Dorry L.
    Garonzik-Wang, Jacqueline
    Paik, Julie J.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (08) : 1100 - 1101
12345